Hpv-positive Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Hpv-positive Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer [Phase 2]
A Phase 2 trial is testing a less intensive radiation regimen with chemotherapy for low-risk HPV-positive oropharyngeal cancer and is curren…
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing weekly cetuximab with radiotherapy versus weekly cisplatin with radiotherapy in HPV-positive oropharyngeal squamous …
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer [Phase 2]
Phase 2 clinical trial evaluating ADXS-11-001 vaccination before robotic surgery in HPV-positive oropharyngeal squamous cell carcinoma has c…